AgeX Therapeutics Inc. (AGE)
AMEX: AGE
· Real-Time Price · USD
11.10
-1.50 (-11.90%)
At close: Mar 26, 2024, 8:59 PM
AgeX Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 14K | 19K | 126K | 158K | 116K | 121K | 73K | 36K | 39K | 34K | 53K | 68K | 93K | 144K | 622K | 1.03M | 1.41M |
Cost of Revenue | 67K | 67K | 34K | 67K | 72K | 73K | 40K | 12K | 13K | 13K | 13K | 10K | 17K | 19K | 56K | 104K | 127K |
Gross Profit | -40K | -35K | 27K | 40K | 44K | 48K | 33K | 24K | 26K | 21K | 40K | 58K | 76K | 125K | 566K | 928K | 1.28M |
Operating Income | -23.85M | -20.31M | -15.06M | -12.1M | -10.12M | -9.96M | -8.18M | -7.38M | -7.08M | -6.97M | -7.06M | -7.18M | -7.8M | -8.04M | -8.62M | -9.35M | -9.77M |
Interest Income | -28K | -28K | 28K | 28K | 820K | 1.92M | 2.87M | 3.79M | 3M | 1.9M | 923K | n/a | n/a | n/a | n/a | n/a | n/a |
Pretax Income | 8.94M | 4.32M | -6.28M | -13.08M | -20.96M | -14.81M | -14.11M | -11.16M | -11.1M | -10.52M | -9.92M | -9.44M | -9.3M | -8.58M | -9.03M | -9.64M | -9.9M |
Net Income | 8.95M | 4.33M | -6.28M | -13.09M | -20.96M | -17.03M | -16.28M | -14.2M | -15.17M | -13.03M | -12.48M | -11.12M | -9.95M | -8.68M | -8.96M | -9.55M | -9.77M |
Selling & General & Admin | 10.94M | 9.25M | 9.89M | 9.15M | 8.55M | 9.33M | 7.48M | 6.7M | 6.3M | 5.97M | 5.91M | 5.94M | 6.35M | 6.71M | 6.92M | 7.45M | 7.35M |
Research & Development | 12.97M | 11.12M | 5.26M | 3.07M | 1.63M | 701K | 760K | 704K | 803K | 1.02M | 1.19M | 1.31M | 1.53M | 1.46M | 2.27M | 2.83M | 3.7M |
Other Expenses | -4K | -4K | 1K | 1K | 5K | 8K | 11K | 13K | 13K | 10K | 9K | 11K | 11K | 11K | 8K | -8K | -31K |
Operating Expenses | 23.91M | 20.38M | 15.15M | 12.19M | 10.17M | 10.01M | 8.21M | 7.4M | 7.11M | 7M | 7.1M | 7.24M | 7.87M | 8.16M | 9.19M | 10.28M | 11.05M |
Interest Expense | -3.72M | -3.82M | -357K | 2.69M | 3.73M | 4.93M | 5.91M | 3.79M | 3.86M | 3.33M | 2.65M | 2.01M | 1.43M | 854K | 559.45K | 274.45K | 447.00 |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 8.87M | 11.2M | 5.94M | 8.34M | 10.24M | 10.08M | 8.26M | 7.41M | 7.12M | 7.01M | 7.11M | 7.25M | 7.89M | 8.18M | 9.24M | 10.38M | 11.18M |
Income Tax Expense | -3.05M | -3.05M | -2K | 3.05M | 3.83M | 6.05M | 6M | 3.83M | 4.07M | 2.51M | 2.56M | 1.67M | 921K | 499K | 359K | 337K | 18K |
Shares Outstanding (Basic) | 9.76M | 7.36M | 8.85M | 8.51M | 4.8M | 1.08M | 1.08M | 1.08M | 1.08M | 1.08M | 1.08M | 1.08M | 1.08M | 1.08M | 1.08M | 1.08M | 1.07M |
Shares Outstanding (Diluted) | 9.76M | 7.36M | 10.75M | 10.16M | 5.62M | 1.08M | 1.08M | 1.08M | 1.08M | 1.08M | 1.08M | 1.08M | 1.08M | 1.08M | 1.08M | 1.08M | 1.07M |
EPS (Basic) | 10.36 | 8.88 | -4.4 | -9.57 | -12.65 | -15.78 | -15.09 | -13.16 | -14.07 | -12.09 | -11.58 | -10.31 | -9.22 | -8.05 | -8.32 | -8.87 | -9.08 |
EPS (Diluted) | 10.23 | 9.04 | -4.24 | -9.38 | -12.36 | -15.78 | -15.09 | -13.16 | -14.07 | -12.09 | -11.58 | -10.31 | -9.22 | -8.05 | -8.32 | -8.87 | -9.08 |
EBITDA | -14.49M | -10.95M | -15.03M | -12.03M | -10.02M | -9.86M | -8.08M | -7.28M | -6.98M | -6.92M | -7M | -7.13M | -7.74M | -8M | -8.33M | -9.1M | -9.55M |
EBIT | 15.4M | 5.87M | -13.05M | -15.4M | -17.29M | -9.94M | -8.21M | -7.37M | -7.24M | -7.19M | -7.27M | -7.42M | -7.87M | -9.91M | -10.66M | -11.7M | -12.32M |
Depreciation & Amortization | -91K | -66K | 58K | 91K | 123K | 134K | 138K | 140K | 145K | 58K | 54K | 51K | 47K | 131K | 675K | 1.01M | 1.35M |